Literature DB >> 20414055

Immunohistochemical overexpression of the p53 protein and Ki-67 (MIB-1) antigen in patients with GERD and chronic esophagitis.

Marcelo Binato1, Renato Fagundes, Richard Gurski, Luise Meurer, Maria Isabel Edelweiss.   

Abstract

BACKGROUND AND STUDY AIMS: Patients with gastroesophageal reflux disease and Barrett esophagus have an increased risk of developing adenocarcinoma of the esophagus. It is uncertain whether molecular or proliferative alterations are present in the early stages of disease.
METHODS: One hundred thirty-eight patients with gastroesophageal reflux disease symptoms were subjected to upper gastrointestinal endoscopy with biopsies of the esophageal mucosa. p53 protein expression and the Ki-67 proliferation index were determined by immunohistochemical studies. Patients were divided into 4 groups according to histopathologic diagnosis: G1, normal epithelium (n=58); G2, mild esophagitis (n=42); G3, moderate esophagitis (n=23), and G4, severe esophagitis (n=15).
RESULTS: p53 overexpression was detected in 7% of G1, 21.4% of G2, 52.2% of G3, and 60% of G4 patients. There were significant differences between G1 and G3 or G4 (P<0.001) and between G2 and G4 (P<0.05). The Ki-67 index was 21.3+/-19.5% in G1, 30.8+/-23.4% in G2, 47.1+/-23.2% in G3, and 48.3+/-25.7% in G4. Significant differences in the Ki-67 index were found between groups: G1 x G3 (P<0.001), G1 x G4 (P<0.001), G2 x G3 (P=0.026), and G2 x G4 (P=0.046). p53 and Ki-67 overexpression were correlated with the severity of esophagitis (P<0.001).
CONCLUSIONS: p53 overexpression and the Ki-67 (MIB-1) index were correlated with histologic findings of inflammation in the esophageal mucosa, particularly in the moderate and severe forms of chronic esophagitis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20414055     DOI: 10.1097/PAI.0b013e3181c49134

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  3 in total

1.  Molecular Marker Expression Is Highly Heterogeneous in Esophageal Adenocarcinoma and Does Not Predict a Response to Neoadjuvant Therapy.

Authors:  Nathan W Bronson; Brian S Diggs; Gene Bakis; Kenneth M Gatter; Brett C Sheppard; John G Hunter; James P Dolan
Journal:  J Gastrointest Surg       Date:  2015-09-22       Impact factor: 3.452

2.  Impact of gastro-oesophageal reflux on microRNA expression, location and function.

Authors:  Cameron M Smith; Michael Z Michael; David I Watson; Grace Tan; David St J Astill; Richard Hummel; Damian J Hussey
Journal:  BMC Gastroenterol       Date:  2013-01-08       Impact factor: 3.067

3.  Changes in Gene Expression Patterns of Circadian-Clock, Transient Receptor Potential Vanilloid-1 and Nerve Growth Factor in Inflamed Human Esophagus.

Authors:  Shu-Chuan Yang; Chien-Lin Chen; Chih-Hsun Yi; Tso-Tsai Liu; Kun-Ruey Shieh
Journal:  Sci Rep       Date:  2015-09-04       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.